View this email online

Stay up-to-date with the latest O&T News in Europe

Read EFORT's official Newsletter with a round up of all EFORT activities

Issue II - November 2023

EFORT e-learning

Have you missed this EFORT Webinar?

Cement Revisited, the EFORT webinar which took place on 25 September 2023 is now available for replay.

Chaired by Rami Madanat, Finland & Bernd Grimm, Luxembourg, it focused on the use of bone cement in orthopaedics.

The objectives of this webinar were: 

  • To understand the history and composition of bone cement 
  • To gain an understanding of the current trends and outcomes of cement use in hip and knee arthroplasty
  • To identify the role of antibiotics and other additives in bone cement 

eScience Webcast highlights

This month's selection from EFORT comprehensive digital library

comprised of +17,900 scientific sessions recorded

Advanced Management Of Complex Tibia Plateau Fractures

Lobenhoffer Approach For Postero-Medial Fractures Of The Proximal Tibia


Thierry Bégué

Now & The Future In


Enabling Technologies




Image Based?


Sébastien Lustig

New Management Concepts For Fracture-Related Infection

A Classification For Fracture-Related Infection: Where Are We Today?


Volker Alt


Evidence from clinical trials on high-risk medical devices in children:

a scoping review

Pediatric Research published a new systematic review on clinical trials.

Meeting increased regulatory requirements for clinical evaluation of medical devices marketed in Europe in accordance with the Medical Device Regulation (EU 2017/745) is challenging, particularly for high-risk devices used in children.

Within the CORE-MD project, the authors performed a scoping review on evidence from clinical trials investigating high-risk paediatric medical devices used in paediatric cardiology, diabetology, orthopaedics and surgery, in patients aged 0–21 years. They searched Medline and Embase from 01 January 2017 to 09 November 2022.

CORE-MD is a European Union Horizon 2020 project. It reviews methods for evaluating high-risk medical devices in order to translate expert evidence into advice for EU regulators and to recommend an appropriate balance between innovation, safety , and clinical effectiveness.


EFORT Resources

A quick access to prime educational material



LinkedInFacebookInstagramTwitterYouTubeEmail Address